Developer docs
API playgroundTry for free, no card

Search company profiles

King Street Properties

Full company profile

uuid00073ry

Namestring
King Street Properties
Legal namestring
King Street Properties
Company typeenum
Private
Founded yearint
2004
Descriptiontext

King Street Properties is a privately held real estate investment management firm founded in 2004 and headquartered in Boston that specializes exclusively in science-based real estate. As of the source data, the company operates a portfolio of approximately 7 million square feet across 22 institutional-grade life science and biomanufacturing properties in five core U.S. research clusters: Greater Boston, New York, the Research Triangle, San Diego, and the San Francisco Bay Area. Tenants span major pharmaceutical manufacturers (Novartis, GSK, Takeda, Novo Nordisk, Sun Pharma), early- and mid-stage biotechnology firms (Voyager Therapeutics, Arrakis Therapeutics, Liquidia, WaVe Life Sciences, Terrestrial Bio/Vaxess), medical device and diagnostic companies (Rover Diagnostics, Interfacial Consultants), academic and clinical research institutions (Duke, BioLabs@NYU Langone, UL Research Institutes), and adjacent clean-tech users (Commonwealth Fusion Systems).

King Street's core offering is purpose-built life science real estate, ranging from turnkey spec laboratory suites (typically 8,500 to 17,700 SF) designed for immediate occupancy, to large custom-built campuses for advanced manufacturing and headquarters needs. Flagship properties include Allston Labworks (585,000 SF mixed-use campus in Allston, MA), The Landing (503,500 SF in Burlingame, CA), Pathway Devens (750,000 SF purpose-built multi-tenant biomanufacturing campus in Devens, MA), Pathway Triangle (978,000 SF across six planned buildings in Morrisville, NC), and Arc UTC/Esplanade (241,963 SF in San Diego). The proprietary Pathway platform is engineered specifically for GMP-compliant biomanufacturing tenants and is reported to reduce time to occupancy by 18-24 months relative to traditional build-out, with newly built or renovated lab space commanding rent premiums of up to 12%.

The business model is recurring long-duration commercial leasing: King Street generates rental revenue from multi-year (life science average ~142 months versus ~44 months for typical office) leases of laboratory, advanced manufacturing, and specialized flex space. The vertically integrated operating model combines acquisition, development, asset management, and tenant relations within a single firm. Tenant origination runs through direct enterprise engagement, supplemented by channel partnerships with major commercial brokerage firms (JLL, CBRE, Cushman & Wakefield, Newmark) and joint-venture co-investment on individual property acquisitions. Pricing is negotiated on a per-lease basis and is not publicly disclosed. The firm is led by Founder/Principal Thomas Ragno, with a senior team of partners and managing directors including recent hires dedicated to the California and North Carolina regional portfolios.

Short descriptiontext

King Street Properties is a Boston-based, private real estate investment management firm that develops, owns, and operates approximately 7 million square feet of purpose-built life science and biomanufacturing real estate across 22 properties in Greater Boston, New York, the Research Triangle, San Diego, and the San Francisco Bay Area, serving pharmaceutical, biotech, medical device, and clean-tech tenants.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science real estate, biomanufacturing facilities, laboratory space leasing, R&D property development, commercial real estate investment
Industry3 codes
PRIMARYBPAJAGAL
Life Sciences/Laboratory Property Management
SECONDARYBPAJALAG
Life Sciences/Lab Tenant Representation
Business & Public Services/Real Estate Services (Brokerage, Property Management)/Real Estate Leasing Services (Tenant Representation)
SECONDARYBPAJAGAF
Healthcare & Medical Office Property Management
NAICS code4 codes
  • Lessors of Nonresidential Buildings (except Miniwarehouses)531120
  • Lessors of Other Real Estate Property53119
  • Real Estate and Rental and Leasing53
  • Real Estate531
SIC code4 codes
  • Lessors Of Real Property, Nec6519
  • Investors, Nec6799
  • Operative Builders1531
  • Real Estate Dealers (For Their Own Account)6532
Product category
Life Science Real Estate
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Commercial Real Estate Leasing
TypeSubscription Recurring
Description

King Street Properties generates revenue through leasing laboratory, office, and advanced manufacturing space to life science companies. They own and operate 7 million square feet of life science real estate across 22 properties in core science submarkets including Greater Boston, New York, the Research Triangle, San Diego, and the San Francisco Bay area. Revenue comes from long-term commercial leases with tenants ranging from startups to large pharmaceutical companies.

kingstreetproperties.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Infrastructure, Operations, Personnel, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1Pathway
Description

Customizable science real estate solution for advanced manufacturing needs, including Pathway Devens (Devens, MA), Pathway Triangle (Morrisville, NC), and Pathway RTP (Research Triangle Park, NC)

kingstreetproperties.com
+6 more records
Core offering1 text field

King Street Properties is a private real estate investment management firm that acquires, develops, owns, and operates life science and biomanufacturing real estate on a national basis. It leases laboratory, R&D, office, and advanced manufacturing space to pharmaceutical, biotechnology, medical device, and clean tech tenants under long-term agreements. Its offering includes purpose-built campuses, GMP-compliant biomanufacturing facilities, and move-in ready spec suites, delivered through a vertically integrated platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduces time to occupancy by 18-24 months compared to traditional build-out
+2 more records
Product overview1 text field

King Street Properties operates as a private real estate investment management firm offering a portfolio of life science and biomanufacturing properties. The company's portfolio includes purpose-built life science campuses (Allston Labworks, The Landing), biomanufacturing campuses (Pathway Devens, Pathway Triangle, Pathway RTP), and converted lab/office properties across Greater Boston, New York, Research Triangle, San Diego, and the San Francisco Bay Area. The properties range from turnkey spec suites for early-stage companies to large-scale advanced manufacturing facilities for pharmaceutical companies. King Street's portfolio totals approximately 7 million SF across 22 properties.

Product and service19 records
1Allston Labworks
CategoryProperty/Life Science Campus
Description

585,000 SF mixed-use life science campus in Allston, MA featuring Class A laboratory space alongside residential apartments, retail, and open-air community areas. Leased to biotech and pharmaceutical tenants.

2The Landing
CategoryProperty/Life Science Campus
Description

503,500 SF life science development in Burlingame, CA, comprising two Class A laboratory and office buildings connected via a public plaza, serving Bay Area biotech and life science tenants.

3Pathway Devens
CategoryProperty/Biomanufacturing Campus
Description

750,000 SF biomanufacturing campus in Devens, MA, designed as the world's first multi-tenant, purpose-built biomanufacturing facility. Leased to pharmaceutical and advanced manufacturing tenants including Commonwealth Fusion Systems.

4Pathway Triangle
CategoryProperty/Biomanufacturing Campus
Description

978,000 SF biomanufacturing campus in Morrisville, NC in the Research Triangle, anticipated across six buildings, leased to pharmaceutical manufacturers including Novartis and Liquidia.

5Pathway RTP
CategoryProperty/Life Science Campus
Description

95-acre pad-ready campus in Research Triangle Park, NC, offering build-to-suit options or a campus site plan with 4 buildings for advanced manufacturing and R&D uses.

6EastRidge at Perimeter Park
CategoryProperty/Life Science Campus
Description

479,000 SF flex/office and life science park in Morrisville, NC, undergoing conversion to an institutional-quality life science campus, with tenants including UL Research Institutes.

7Innolabs
CategoryProperty/Life Science Building
Description

266,800 SF Class A life science project in Long Island City, NY, featuring multi-tenant floors and purpose-built lab infrastructure, including a 46,000 SF biotech incubator with BioLabs@NYU Langone.

8Arc UTC (Esplanade)
CategoryProperty/Life Science Campus
Description

241,963 SF multi-building life science campus in San Diego's University Town Center (UTC) cluster, comprising three research buildings acquired in late 2024.

9Mesa Labworks
CategoryProperty/Life Science Campus
Description

62,000 SF life science campus in San Diego's Sorrento Mesa submarket, converted from flex office to move-in ready labs with modern infrastructure, with tenants including Interfacial Consultants.

10100-125-150 Cambridgepark Drive
CategoryProperty/Life Science Campus
Description

684,000 SF campus in Cambridge, MA consisting of three buildings next to Alewife station, with outdoor event space and on-site amenities for life science tenants.

11200 Cambridgepark Drive
CategoryProperty/Office/Lab Building
Description

222,000 SF office/laboratory building in Cambridge's Alewife area, originally built for a major pharmaceutical company.

12733 Concord Avenue
CategoryProperty/Life Science Building
Description

44,000 SF life science building in Concord, MA, 100% leased to WaVe Life Sciences for nucleic acid therapeutics R&D.

13Research Laboratory (Durham)
CategoryProperty/Life Science Building
Description

51,174 SF life science building in Durham, NC, 100% occupied by the Duke Clinical Research Institute for clinical research.

14Carmichael Building
CategoryProperty/R&D Building
Description

114,000 SF R&D lab space in downtown Durham, NC, 100% leased to Duke University.

15359 Allston Street
CategoryProperty/Life Science Building
Description

7,517 SF life science building in Cambridge, MA, fully leased as the headquarters of Vaxess Technologies (now Terrestrial Bio) for vaccine technology development.

16828-830 Winter Street
CategoryProperty/Lab Building
Description

327,000 SF lab building in Waltham, MA featuring cutting-edge MEP systems, originally developed by King Street in a joint venture from 2015 onward.

171499 Bayshore
CategoryProperty/Development Opportunity
Description

Approximately 320,000 SF life science development opportunity in Burlingame, CA currently in permitting, extending the firm's Bay Area pipeline.

18First
CategoryProperty/Development
Description

460,000 SF life sciences campus in Waltham, MA featuring two 5-story buildings with high visibility signage for life science tenants.

19287 Western Ave
CategoryProperty/Development
Description

95,000 SF development in Allston, MA featuring Class A laboratory and office suites with flexible high bay space for life science tenants.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

GFP Real Estate is a Manhattan-based development partner collaborating with King Street Properties on the Innolabs project in Long Island City, NY. King Street Properties serves as the Boston-based developer while GFP Real Estate contributes local New York development expertise.

Strategic tierKeyTypeTechnology or Integration
Description

Perkins & Will serves as the architect for The Landing in Burlingame and other King Street Properties projects. The firm designed the campus as a purpose-built life science environment with flexible infrastructure supporting diverse research needs.

Strategic tierKeyTypeImplementation/ SI/ Consulting Partner
Description

BW Kennedy & Co. serves as general contractor for multiple Pathway Devens buildings. The partnership has resulted in construction of five buildings at the biomanufacturing campus.

Strategic tierKeyTypeImplementation/ SI/ Consulting Partner
Description

Hathaway Dinwiddie serves as general contractor for The Landing development in Burlingame, CA.

Strategic tierSecondaryTypeTechnology or Integration
Description

SWA Group serves as landscape architect for The Landing campus in Burlingame.

Strategic tierKeyTypeChannel Partner/ Reseller/ Distributor
Description

JLL (Jones Lang LaSalle) handles leasing for The Landing property and represents King Street in multiple transactions across their portfolio.

Strategic tierKeyTypeChannel Partner/ Reseller/ Distributor
Description

CBRE represented King Street Properties in the Novartis lease transaction at Pathway Triangle.

Strategic tierKeyTypeChannel Partner/ Reseller/ Distributor
Description

Cushman & Wakefield brokered the UL Research Institutes lease at EastRidge and provides tenant representation services.

Strategic tierSecondaryTypeChannel Partner/ Reseller/ Distributor
Description

Newmark represented the seller in the acquisition of 359 Allston Street.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The largest pure-play publicly traded life science REIT. Operates mission-critical lab and biomanufacturing campuses across the same major US clusters (Boston, SF Bay, San Diego, NYC, Research Triangle), directly competing for tenants like Novartis, GSK, and Takeda.

TypeDirect peer
Description

Private life science REIT owned by Blackstone; one of the largest owners of life science real estate. Competes head-to-head in Cambridge/Boston, San Diego, and the Bay Area with similar turnkey lab and GMP-capable product.

TypeDirect peer
Description

Developer and operator of purpose-built, mixed-use life science and innovation districts; competes for institutional and university-anchored life science tenants across major US research hubs.

TypeDirect peer
Description

San Diego-headquartered life science real estate developer focused on large-scale, purpose-built lab and biomanufacturing product — direct competitor in Southern California and gateway US life science clusters.

TypeDirect peer
Description

Boston-based vertically integrated life science developer and operator; competes closely with King Street in Greater Boston, the Bay Area, and Research Triangle on both spec lab and build-to-suit product.

TypeBroad incumbent
Description

Diversified West Coast office REIT with an established life science platform concentrated in California. Competes for Bay Area and San Diego tenants like those targeted by King Street's California assets (The Landing, Mesa Labworks).

TypeEmerging player
Description

Private equity-backed real estate investor with growing life science and R&D focus; positioned as a smaller, faster-moving competitor pursuing similar lab/biomanufacturing opportunities in Tier-1 US markets.

8Breakline Capital
TypeEmerging player
Description

Newer entrant focused on purpose-built life science and biomanufacturing facilities; competes with King Street's Pathway approach by offering turnkey, GMP-ready space to emerging therapeutics and CDMOs.

TypeEmerging player
Description

Specialized developer of medical office and healthcare-adjacent facilities with growing exposure to life science tenants; adjacent competitor for capital-constrained academic and biotech tenants.

TypeOthers
Description

Commercial real estate services and capital markets firm; competes less on ownership but acts as a leasing advisor and capital provider in many of the same transactions where King Street participates as principal.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

King Street Properties

Life Science Real Estatekingstreetproperties.com

King Street Properties is a Boston-based, private real estate investment management firm that develops, owns, and operates approximately 7 million square feet of purpose-built life science and biomanufacturing real estate across 22 properties in Greater Boston, New York, the Research Triangle, San Diego, and the San Francisco Bay Area, serving pharmaceutical, biotech, medical device, and clean-tech tenants.

What King Street Properties does

King Street Properties is a privately held real estate investment management firm founded in 2004 and headquartered in Boston that specializes exclusively in science-based real estate. As of the source data, the company operates a portfolio of approximately 7 million square feet across 22 institutional-grade life science and biomanufacturing properties in five core U.S. research clusters: Greater Boston, New York, the Research Triangle, San Diego, and the San Francisco Bay Area. Tenants span major pharmaceutical manufacturers (Novartis, GSK, Takeda, Novo Nordisk, Sun Pharma), early- and mid-stage biotechnology firms (Voyager Therapeutics, Arrakis Therapeutics, Liquidia, WaVe Life Sciences, Terrestrial Bio/Vaxess), medical device and diagnostic companies (Rover Diagnostics, Interfacial Consultants), academic and clinical research institutions (Duke, BioLabs@NYU Langone, UL Research Institutes), and adjacent clean-tech users (Commonwealth Fusion Systems).

King Street's core offering is purpose-built life science real estate, ranging from turnkey spec laboratory suites (typically 8,500 to 17,700 SF) designed for immediate occupancy, to large custom-built campuses for advanced manufacturing and headquarters needs. Flagship properties include Allston Labworks (585,000 SF mixed-use campus in Allston, MA), The Landing (503,500 SF in Burlingame, CA), Pathway Devens (750,000 SF purpose-built multi-tenant biomanufacturing campus in Devens, MA), Pathway Triangle (978,000 SF across six planned buildings in Morrisville, NC), and Arc UTC/Esplanade (241,963 SF in San Diego). The proprietary Pathway platform is engineered specifically for GMP-compliant biomanufacturing tenants and is reported to reduce time to occupancy by 18-24 months relative to traditional build-out, with newly built or renovated lab space commanding rent premiums of up to 12%.

The business model is recurring long-duration commercial leasing: King Street generates rental revenue from multi-year (life science average ~142 months versus ~44 months for typical office) leases of laboratory, advanced manufacturing, and specialized flex space. The vertically integrated operating model combines acquisition, development, asset management, and tenant relations within a single firm. Tenant origination runs through direct enterprise engagement, supplemented by channel partnerships with major commercial brokerage firms (JLL, CBRE, Cushman & Wakefield, Newmark) and joint-venture co-investment on individual property acquisitions. Pricing is negotiated on a per-lease basis and is not publicly disclosed. The firm is led by Founder/Principal Thomas Ragno, with a senior team of partners and managing directors including recent hires dedicated to the California and North Carolina regional portfolios.

King Street Properties firmographics

Firmographics
Name
King Street Properties
Legal name
King Street Properties
Website
https://kingstreetproperties.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
King Street Properties is a Boston-based, private real estate investment management firm that develops, owns, and operates approximately 7 million square feet of purpose-built life science and biomanufacturing real estate across 22 properties in Greater Boston, New York, the Research Triangle, San Diego, and the San Francisco Bay Area, serving pharmaceutical, biotech, medical device, and clean-tech tenants.
Ownership category
akta.pro rank

King Street Properties industry classification

Industry
Product category
Life Science Real Estate
NAICS
Lessors of Nonresidential Buildings (except Miniwarehouses) (531120), Lessors of Other Real Estate Property (53119), Real Estate and Rental and Leasing (53), Real Estate (531)
SIC
Lessors Of Real Property, Nec (6519), Investors, Nec (6799), Operative Builders (1531), Real Estate Dealers (For Their Own Account) (6532)
akta.pro industry
PRIMARYBPAJAGAL
Life Sciences/Laboratory Property Management
SECONDARYBPAJALAG
Life Sciences/Lab Tenant Representation
Business & Public Services/Real Estate Services (Brokerage, Property Management)/Real Estate Leasing Services (Tenant Representation)
SECONDARYBPAJAGAF
Healthcare & Medical Office Property Management

Keywords

  • Life science real estate
  • Biomanufacturing facilities
  • Laboratory space leasing
  • R&D property development
  • Commercial real estate investment

Where King Street Properties is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

King Street Properties business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Operations, Personnel, Supply Chain, Marketing or Sales

Revenue model

  1. Commercial Real Estate Leasing: King Street Properties generates revenue through leasing laboratory, office, and advanced manufacturing space to life science companies. They own and operate 7 million square feet of life science real estate across 22 properties in core science submarkets including Greater Boston, New York, the Research Triangle, San Diego, and the San Francisco Bay area. Revenue comes from long-term commercial leases with tenants ranging from startups to large pharmaceutical companies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

King Street Properties product offering

Product offering

Core offering

King Street Properties is a private real estate investment management firm that acquires, develops, owns, and operates life science and biomanufacturing real estate on a national basis. It leases laboratory, R&D, office, and advanced manufacturing space to pharmaceutical, biotechnology, medical device, and clean tech tenants under long-term agreements. Its offering includes purpose-built campuses, GMP-compliant biomanufacturing facilities, and move-in ready spec suites, delivered through a vertically integrated platform.

Product overview

King Street Properties operates as a private real estate investment management firm offering a portfolio of life science and biomanufacturing properties. The company's portfolio includes purpose-built life science campuses (Allston Labworks, The Landing), biomanufacturing campuses (Pathway Devens, Pathway Triangle, Pathway RTP), and converted lab/office properties across Greater Boston, New York, Research Triangle, San Diego, and the San Francisco Bay Area. The properties range from turnkey spec suites for early-stage companies to large-scale advanced manufacturing facilities for pharmaceutical companies. King Street's portfolio totals approximately 7 million SF across 22 properties.

Differentiator

Problem solved

Functional benefit

Brands

  • Pathway: Customizable science real estate solution for advanced manufacturing needs, including Pathway Devens (Devens, MA), Pathway Triangle (Morrisville, NC), and Pathway RTP (Research Triangle Park, NC)
  • Allston Labworks
  • The Landing
  • Mesa Labworks
  • EastRidge at Perimeter Park
  • Innolabs
  • Arc UTC

Products and services

  • Allston Labworks 585,000 SF mixed-use life science campus in Allston, MA featuring Class A laboratory space alongside residential apartments, retail, and open-air community areas. Leased to biotech and pharmaceutical tenants.
  • The Landing 503,500 SF life science development in Burlingame, CA, comprising two Class A laboratory and office buildings connected via a public plaza, serving Bay Area biotech and life science tenants.
  • Pathway Devens 750,000 SF biomanufacturing campus in Devens, MA, designed as the world's first multi-tenant, purpose-built biomanufacturing facility. Leased to pharmaceutical and advanced manufacturing tenants including Commonwealth Fusion Systems.
  • Pathway Triangle 978,000 SF biomanufacturing campus in Morrisville, NC in the Research Triangle, anticipated across six buildings, leased to pharmaceutical manufacturers including Novartis and Liquidia.
  • Pathway RTP 95-acre pad-ready campus in Research Triangle Park, NC, offering build-to-suit options or a campus site plan with 4 buildings for advanced manufacturing and R&D uses.
  • EastRidge at Perimeter Park 479,000 SF flex/office and life science park in Morrisville, NC, undergoing conversion to an institutional-quality life science campus, with tenants including UL Research Institutes.
  • Innolabs 266,800 SF Class A life science project in Long Island City, NY, featuring multi-tenant floors and purpose-built lab infrastructure, including a 46,000 SF biotech incubator with BioLabs@NYU Langone.
  • Arc UTC (Esplanade) 241,963 SF multi-building life science campus in San Diego's University Town Center (UTC) cluster, comprising three research buildings acquired in late 2024.
  • Mesa Labworks 62,000 SF life science campus in San Diego's Sorrento Mesa submarket, converted from flex office to move-in ready labs with modern infrastructure, with tenants including Interfacial Consultants.
  • 100-125-150 Cambridgepark Drive 684,000 SF campus in Cambridge, MA consisting of three buildings next to Alewife station, with outdoor event space and on-site amenities for life science tenants.
  • 200 Cambridgepark Drive 222,000 SF office/laboratory building in Cambridge's Alewife area, originally built for a major pharmaceutical company.
  • 733 Concord Avenue 44,000 SF life science building in Concord, MA, 100% leased to WaVe Life Sciences for nucleic acid therapeutics R&D.
  • Research Laboratory (Durham) 51,174 SF life science building in Durham, NC, 100% occupied by the Duke Clinical Research Institute for clinical research.
  • Carmichael Building 114,000 SF R&D lab space in downtown Durham, NC, 100% leased to Duke University.
  • 359 Allston Street 7,517 SF life science building in Cambridge, MA, fully leased as the headquarters of Vaxess Technologies (now Terrestrial Bio) for vaccine technology development.
  • 828-830 Winter Street 327,000 SF lab building in Waltham, MA featuring cutting-edge MEP systems, originally developed by King Street in a joint venture from 2015 onward.
  • 1499 Bayshore Approximately 320,000 SF life science development opportunity in Burlingame, CA currently in permitting, extending the firm's Bay Area pipeline.
  • First 460,000 SF life sciences campus in Waltham, MA featuring two 5-story buildings with high visibility signage for life science tenants.
  • 287 Western Ave 95,000 SF development in Allston, MA featuring Class A laboratory and office suites with flexible high bay space for life science tenants.

Quantifiable outcome

  • Reduces time to occupancy by 18-24 months compared to traditional build-out
  • +2 more outcomes

Companies that use King Street Properties

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles4 records

King Street Properties technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

King Street Properties partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, key and secondary.

  • GFP Real EstatecoreStrategic or Co-development PartnerGFP Real Estate is a Manhattan-based development partner collaborating with King Street Properties on the Innolabs project in Long Island City, NY. King Street Properties serves as the Boston-based developer while GFP Real Estate contributes local New York development expertise.
  • Perkins & WillkeyTechnology or IntegrationPerkins & Will serves as the architect for The Landing in Burlingame and other King Street Properties projects. The firm designed the campus as a purpose-built life science environment with flexible infrastructure supporting diverse research needs.
  • BW Kennedy & Co. (BWK)keyImplementation/ SI/ Consulting PartnerBW Kennedy & Co. serves as general contractor for multiple Pathway Devens buildings. The partnership has resulted in construction of five buildings at the biomanufacturing campus.
  • Hathaway DinwiddiekeyImplementation/ SI/ Consulting PartnerHathaway Dinwiddie serves as general contractor for The Landing development in Burlingame, CA.
  • SWA GroupsecondaryTechnology or IntegrationSWA Group serves as landscape architect for The Landing campus in Burlingame.
  • JLLkeyChannel Partner/ Reseller/ DistributorJLL (Jones Lang LaSalle) handles leasing for The Landing property and represents King Street in multiple transactions across their portfolio.
  • CBREkeyChannel Partner/ Reseller/ DistributorCBRE represented King Street Properties in the Novartis lease transaction at Pathway Triangle.
  • Cushman & WakefieldkeyChannel Partner/ Reseller/ DistributorCushman & Wakefield brokered the UL Research Institutes lease at EastRidge and provides tenant representation services.
  • NewmarksecondaryChannel Partner/ Reseller/ DistributorNewmark represented the seller in the acquisition of 359 Allston Street.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

King Street Properties competitors and assessment

Company assessment

Direct peers

  • Alexandria Real Estate Equities: The largest pure-play publicly traded life science REIT. Operates mission-critical lab and biomanufacturing campuses across the same major US clusters (Boston, SF Bay, San Diego, NYC, Research Triangle), directly competing for tenants like Novartis, GSK, and Takeda.
  • BioMed Realty (Blackstone): Private life science REIT owned by Blackstone; one of the largest owners of life science real estate. Competes head-to-head in Cambridge/Boston, San Diego, and the Bay Area with similar turnkey lab and GMP-capable product.
  • Wexford Science & Technology: Developer and operator of purpose-built, mixed-use life science and innovation districts; competes for institutional and university-anchored life science tenants across major US research hubs.
  • IQHQ: San Diego-headquartered life science real estate developer focused on large-scale, purpose-built lab and biomanufacturing product — direct competitor in Southern California and gateway US life science clusters.
  • Longfellow Real Estate Partners: Boston-based vertically integrated life science developer and operator; competes closely with King Street in Greater Boston, the Bay Area, and Research Triangle on both spec lab and build-to-suit product.

Broad incumbents

  • Kilroy Realty: Diversified West Coast office REIT with an established life science platform concentrated in California. Competes for Bay Area and San Diego tenants like those targeted by King Street's California assets (The Landing, Mesa Labworks).

Emerging players

  • Trinity Hunt Partners: Private equity-backed real estate investor with growing life science and R&D focus; positioned as a smaller, faster-moving competitor pursuing similar lab/biomanufacturing opportunities in Tier-1 US markets.
  • Breakline Capital: Newer entrant focused on purpose-built life science and biomanufacturing facilities; competes with King Street's Pathway approach by offering turnkey, GMP-ready space to emerging therapeutics and CDMOs.
  • Anchor Health Properties: Specialized developer of medical office and healthcare-adjacent facilities with growing exposure to life science tenants; adjacent competitor for capital-constrained academic and biotech tenants.

Others

  • Newmark Group: Commercial real estate services and capital markets firm; competes less on ownership but acts as a leasing advisor and capital provider in many of the same transactions where King Street participates as principal.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

King Street Properties social profiles

Digital presence

King Street Properties financial estimates

Financial estimate

Revenue estimate

Valuation estimate

King Street Properties leadership team

Management profile

Number of profiles

Profiles13 records

King Street Properties funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

King Street Properties M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about King Street Properties

What does King Street Properties do?

King Street Properties is a private real estate investment management firm that acquires, develops, owns, and operates life science and biomanufacturing real estate on a national basis. It leases laboratory, R&D, office, and advanced manufacturing space to pharmaceutical, biotechnology, medical device, and clean tech tenants under long-term agreements. Its offering includes purpose-built campuses, GMP-compliant biomanufacturing facilities, and move-in ready spec suites, delivered through a vertically integrated platform.

Is King Street Properties a public or private company?

King Street Properties is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was King Street Properties founded?

King Street Properties was founded in 2004. It employs 11 to 50 people.

Where is King Street Properties based?

King Street Properties is headquartered in Boston, United States, in the North America region.

How does King Street Properties make money?

One revenue line is on record: commercial Real Estate Leasing.

Who are King Street Properties's main competitors?

Direct peers on record are Alexandria Real Estate Equities, BioMed Realty (Blackstone), Wexford Science & Technology, IQHQ and Longfellow Real Estate Partners. Kilroy Realty is listed as a broad incumbent. Emerging players are Trinity Hunt Partners, Breakline Capital and Anchor Health Properties. Newmark Group is listed as an others.

Does King Street Properties have an API?

No public API is recorded for King Street Properties.

What industry is King Street Properties in?

King Street Properties's product category is Life Science Real Estate. Its primary akta.pro industry code is BPAJAGAL, Life Sciences/Laboratory Property Management, with a secondary code of BPAJALAG, Life Sciences/Lab Tenant Representation. Its NAICS code is 531120 and its SIC code is 6519.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CommercialSearchKing Street Lands $238M for Research Triangle CampusKing Street Properties secured a $237.7 million loan for Pathway Triangle, a life science campus in Morrisville, N.C., backed by JLL and Starwood Property Trust. The financing covers the first phase, anchored by Novartis, which signed a full-building lease in late 2025. The campus will eventually include seven buildings totaling over 950,000 square feet.Connect CREKing Street’s Allston Labworks Signs First Biotech TenantKing Street Properties has secured Terrestrial Bio as the first biotech tenant for its Allston Labworks development in Boston, signing a lease for 42,000 square feet. The company is relocating its headquarters from Woburn and will occupy lab, office, and manufacturing space within a custom-built GMP facility constructed by King Street. This agreement marks a significant milestone for the mixed-use development, which had previously leased over 150,000 square feet to retail and other entities.American City Business JournalsKing Street to build another Pathway Devens advanced manufacturing siteKing Street Properties closed on a $75 million construction loan to build a 210,000-square-foot advanced manufacturing plant at its Pathway Devens campus. The loan comes from First Citizens Bank and Berkshire Bank, and no tenant has yet signed a lease for the site. The building is expected to be completed in the third quarter of 2025.PR NewswireBrookfield Forms Strategic Partnership with Boston-Based King Street PropertiesKing Street Properties, a Boston-based private developer specializing in life science real estate, has formed a strategic partnership with Brookfield Asset Management to invest approximately $1.5 billion in equity capital toward life science real estate across the US. Brookfield also entered into an agreement to purchase an interest in King Street's operating platform, while King Street retains ownership of its existing portfolio of 2.5 million square feet of stabilized assets and 2.3 million square feet under development. The partnership combines King Street's two decades of sector expertise with Brookfield's financial resources to scale operations in established and emerging life science markets including biomanufacturing.Boston Real Estate TimesKing Street Properties and Carlyle Sell Framingham Assets to Oxford Properties for $151 MillionKing Street Properties and The Carlyle Group have sold two life science assets in Framingham, Massachusetts, to Oxford Properties for $151 million. The transaction involves 33 New York Avenue, a bio-manufacturing facility leased by Replimune Group and CRISPR Therapeutics, and 1 & 5 Mountain Road, which is currently occupied by Sanofi Genzyme.